Perfusion Index in Pediatric Low-Flow Anesthesia
Changes in Perfusion Index Under Low-Flow Anesthesia and Its Effects on Postoperative Emergence in Pediatric Patients
Istinye University
90 participants
Jun 15, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate changes in perfusion index (PI) in pediatric patients undergoing elective surgery under low-flow anesthesia. PI will be monitored at multiple intraoperative and postoperative time points to assess its relationship with hemodynamic stability and depth of anesthesia. The study will also investigate whether low-flow anesthesia affects the incidence of emergence agitation (EA). Patients will be assigned to either low-flow or normal-flow anesthesia groups based on routine clinical practice. No intervention will be applied beyond standard care. The findings are expected to provide insight into the predictive value of PI in postoperative recovery and support safer anesthesia practices in pediatric populations.
Eligibility
Inclusion Criteria4
- ASA I-II pediatric patients
- Age 2 to 12 years
- Undergoing elective surgery lasting between 1-6 hours
- Informed consent obtained from parents/guardians
Exclusion Criteria13
- Cardiovascular, respiratory, neurological, metabolic, or endocrine disorders
- Premature birth with corrected age \< 2 years
- Obesity or severe malnutrition (BMI \<5th or \>95th percentile)
- Psychiatric or neurodevelopmental disorders (e.g., autism)
- Malignant hyperthermia or hypersensitivity to anesthetics
- Emergency surgeries
- Lack of IV access requiring inhalational induction
- Contraindications to low-flow anesthesia including:
- Severe pulmonary disease
- Congenital heart disease with shunt physiology
- Anticipated high oxygen demand
- Airway obstruction risk
- Surgeries requiring high gas flow or \>6 hours duration
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
General anesthesia with a fresh gas flow rate of 1 L/min (50% oxygen + 50% air).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06967675